Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-24-100218
Filing Date
2024-11-19
Accepted
2024-11-19 17:03:54
Documents
61
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ea0221563-10q_klotho.htm   iXBRL 10-Q 637320
2 KLOTHO NEUROSCIENCES, INC. INSIDER TRADING POLICY ea022156301ex19-1_klotho.htm EX-19.1 54935
3 CERTIFICATION ea022156301ex31-1_klotho.htm EX-31.1 10781
4 CERTIFICATION ea022156301ex31-2_klotho.htm EX-31.2 10761
5 CERTIFICATION ea022156301ex32-1_klotho.htm EX-32.1 4089
6 CERTIFICATION ea022156301ex32-2_klotho.htm EX-32.2 3910
  Complete submission text file 0001213900-24-100218.txt   4510282

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE klto-20240930.xsd EX-101.SCH 42660
8 XBRL CALCULATION FILE klto-20240930_cal.xml EX-101.CAL 23416
9 XBRL DEFINITION FILE klto-20240930_def.xml EX-101.DEF 240653
10 XBRL LABEL FILE klto-20240930_lab.xml EX-101.LAB 372524
11 XBRL PRESENTATION FILE klto-20240930_pre.xml EX-101.PRE 235530
63 EXTRACTED XBRL INSTANCE DOCUMENT ea0221563-10q_klotho_htm.xml XML 447241
Mailing Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010
Business Address 1115 BROADWAY 12TH FLOOR NEW YORK NY 10010 646-916-5315
Klotho Neurosciences, Inc. (Filer) CIK: 0001907223 (see all company filings)

EIN.: 862727441 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41340 | Film No.: 241477118
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)